On Sep 16, 2021 IASO Biotherapeutics closed a Series C round and raised $108,000,000 from CCB International, CDH Investments, CNCB Capital, Co-Stone Venture Capital, Everbright, GL Ventures, Plaisance Capital, featuring lead investors CDH Investments.
About the company: IASO Biotherapeutics is located at China, Asia.
“”
Company website: http://www.iasobio.com